Follow our expert insights on treatment options, Dx codes, and documentation.
Spider vein and varicose vein treatments are increasingly common procedures at dermatology practices — and just as common are the struggles to code and bill them correctly. If a vein treatment is medically necessary, follow the expert advice below to get your deserved reimbursement.
Know the Sclerosing Solution Injection Basics
The problematic veins your dermatologist is most likely to be faced with fall into two categories: spider veins and varicose veins, says Pamela Biffle, CPC, CPC-P, CPC-I, CPCO, owner of PB Healthcare Consulting and Education Inc. in Austin, Texas.
Spider veins: Also known as telangiectases or roadmap veins, these are “very tiny superficial blood vessels that increase in size over time and commonly occur on the legs,” according to the American Academy of Dermatology.
Varicose veins: These are larger, dilated blood vessels that can be raised above the skin’s surface and have a rope-like appearance, the AAD says.
Treatment: A common treatment is an injection of a medicine into the affected blood vessels to shrink them. These injections of sclerosing solutions are described with CPT® codes 36468-36471.
Medicare rules: CPT® has specific codes for sclerosing injections:
However, don’t count on reimbursement from Medicare for spider vein treatments. As Part B carrier National Government Services puts it in its local coverage determination (LCD), “Spider veins … are most often treated for cosmetic purposes. Treatment of telangiectases is not covered by Medicare.”
Understand the Varicose Treatments
Ligation and stripping is a proven treatment for varicose veins, reported by dermatologists with CPT® codes:
Another therapy for treating varicose veins is radiofrequency, says the AAD. During this procedure, radiofrequency energy converted to heat is used to collapse the vein, which is then reabsorbed by the body, the Academy explains. Radiofrequency is described by CPT® codes:
Laser therapy is one of the latest treatments for varicose veins, in which tiny laser fibers are delivered to the vein through a needle puncture that is threaded up to the main vein trunk responsible for these veins, says the AAD. This is described by CPT® codes:
Prove Medical Necessity
Although Medicare has no national coverage determination (NCD) for varicose vein treatments, several local Part B carriers, such as National Government Services, have LCDs. NGS’s policy states that Medicare will consider interventional treatment of varicose veins medically necessary if the patient remains symptomatic after a six-week trial of conservative therapy. The components of the conservative therapy include, but are not limited to:
“The conservative therapy must be documented in the medical record,” says NGS.
The patient is considered symptomatic if any of the following signs and symptoms of significantly diseased vessels of the lower extremities are documented in the medical record, the Part B carrier says:
Although not limited to these diagnoses, NGS lists these ICD-9 codes as supporting medical necessity for varicose vein treatments:
Keep Your Documentation Solid
The patient’s medical record must contain documentation that fully supports the medical necessity for services, cautions NGS. “This documentation includes, but is not limited to, relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures.”
Specifically, the LCD requires that the patient’s medical record must document:
“The medical record must also include pre-treatment photographs of the varicose veins for which claims for sclerotherapy are submitted to Medicare,” says NGS. “These photographs must be made available to the carrier upon request for review.”